NCT07098806View on ClinicalTrials.gov

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

October 2, 2026

Study Completion Date

October 2, 2031

Conditions
Leptomeningeal Metastasis
Interventions
DRUG

186RNL

Multiple Doses of 186RNL

Trial Locations (1)

78229

RECRUITING

The Cancer Therapy and Research Center at UTHSCSA, San Antonio

Sponsors

Lead Sponsor

Plus Therapeutics
All Listed Sponsors
lead

Plus Therapeutics

INDUSTRY